Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06765694

Efficacy of One or Two Botulinum Toxin Injections in the Treatment of Chronic Lateral Epicondylalgia: a Retrospective Study (EPITOX)

Efficacy of One or Two Botulinum Toxin Injections in the Treatment of Chronic Lateral Epicondylalgia: a Retrospective Study

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
University Hospital, Brest · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Despite being a self-limiting injury, lateral epicondylitis (LE) can be difficult to manage. In cases of refractory LE, conservative treatment fails and symptoms persist over 6 months. Previous studies have investigated the role of botulinum Toxin Type A (BoNT-A) injections in LE with controversial results. There is some evidence that repeating the BoNT-A injection could be beneficial for refractory cases. The objective is to assess the success rate of one or two BoNT-A injections for refractory LE.

Conditions

Interventions

TypeNameDescription
DRUGBotulinum toxin injectionfirst injection was done under ultrasound control in the extensor carpi radialis brevis (ECRB). The second one if necessary was subordinated to clinical examination and focused in one or more of the following: ECRB, extensor digitorum communis, supinator.

Timeline

Start date
2024-11-01
Primary completion
2025-10-31
Completion
2025-10-31
First posted
2025-01-09
Last updated
2025-01-09

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06765694. Inclusion in this directory is not an endorsement.